Digital Brave New Commercialisation World: Frontiers Health 2025 In today's commercial landscape, companies face unprecedented challenges. Hear from policy experts at Frontiers Health '25 about this brave new world.
R&D Reimagining biopharma: How AI is reshaping discovery, develo... No longer confined to experimental pilots, AI is becoming a catalyst for change across the entire biopharma value chain - but there are challenges.
R&D Sponsored A New Framework to Engineer Breakthrough Value for Medicines A new white paper from Lumanity – ‘A New Framework to Engineer Breakthrough Value for Medicines: Value Inflection Points Across the Development Path’.
Partner Content Partner Content Citius Oncology Signs Exclusive Commercialization Agreement ... Citius Oncology Signs Exclusive Commercialization Agreement with EVERSANA to Support Planned Q4 2025 Launch of LYMPHIR™
Sales & Marketing 5 Things to watch at Fierce Pharma Week 2025: What every pha... Fierce Pharma Week 2025, 8th to 11th September 2025 in Philadelphia marks a historic shift in pharmaceutical industry events.
Patients LSX2026: On promise and patience, with Hans Schambye At LSX World Congress 2026 in Lisbon, Portugal, web editor Nicole Raleigh spoke with Hans Schambye, CEO of BOOST Pharma.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.